Method for preparing PD-1 gene-deficient type PD-1-CART cell preparation
A PD-1-CART and PD-1-CAR technology, applied in the field of molecular biology, can solve the problems of large side effects and poor targeting, and achieve the effect of reducing side effects and reducing side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0045] (1) PD-1 gene-deficient T lymphocytes
[0046]Prepare PD-1 gene-deficient T lymphocytes according to the method described in patent ZL201710649967.6.
[0047] (2) Design of ITSM motif tyrosine mutation
[0048] The original tyrosine codon TAT in the ITSM motif was replaced with the codon TTT to mutate tyrosine into phenylalanine.
[0049] (3) PD-1+4-1BB+CD3ζ chimeric CAR design
[0050] For the chimeric 4-1BB (214-255aa) and CD3ζ (52-163aa) peptides after the PD-1 peptide, send the designed sequence to Shanghai Sangon Bioengineering Co. Add an EcoRI site, add a Spel site after the TGA stop codon at the 3' end, and then clone into the pMD18-T vector, named pMD18-T-CAR.
[0051] (4) Construction of pSin-EF2-Pur-CAR vector
[0052] a. Two plasmids, pMD18-T-CAR and pSin-EF2-Sox2-Pur, were digested with EcoR I and Spe l, and the enzyme digestion reaction system was:
[0053]
[0054] React at 37°C for half an hour, and then perform 1.0% agarose gel electrophoresis. ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com